Business● Low4d ago · Nov 3, 2026, 2:09 AM
Neurocrine expects double-digit 2027 INGREZZA volume growth despite mid- to high single-digit net pricing headwinds
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Neurocrine anticipates double-digit volume growth for its INGREZZA product in 2027, even while facing mid-to-high single-digit net pricing challenges. This indicates the company's financial projections for a key product.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business19m agoEarn points, save cash: A basic guide to frequent-flyer programmes in EuropeEuroNews [en]Business19m agoFinancial leaders tiptoe around Beijing’s asset scrutiny, hail Hong Kong’s wealth boomSouth China Morning PostBusiness19m ago'We have proven ourselves': UAE vows to remain reliable energy supplier to EuropeEuroNews [en]Business20m agoAre Europeans saving enough for retirement? Here is how much more they need to put asideEuroNews [en]